• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA warns on pain drugs for implantable pumps

November 14, 2018 By Sarah Faulkner

FDA-logo-new

The FDA today warned doctors and patients about the serious complications that can occur when using the wrong painkillers with implantable drug pumps.

Dosing errors, pump failure, and infection are just some of the potential problems that can crop up when using drugs that aren’t approved for use with particular devices, the regulatory agency said.

“The treatment of pain has become increasingly complex. While medical devices, such as implanted pumps that deliver medication directly into the spinal fluid, have the potential to play an important role in treating pain, their use must be judicious and their instructions for use must be carefully followed. This is especially true when it comes to implantable pumps that deliver analgesic medicine directly into the nervous system,” FDA commissioner Dr. Scott Gottlieb said in prepared remarks.

There are drugs that are specifically approved for intrathecal administration. These painkillers have to meet certain safety standards since they are targeted directly to the spinal cord and brain tissue.

The FDA said that it’s seen some cases where patients are being treated with drugs like fentanyl and clonidine with an intrathecal implanted pump.

The agency also noted that some medicines may have preservatives or features that damage the pump tubing or corrode the pumping mechanism, leading to pump failure.

The FDA recommended that healthcare providers review the pump’s labeling to verify the kinds of medicines approved for use with the pump. Patients who experience an adverse event related to an implanted pump should file a voluntary report through the FDA’s MedWatch program.

“We urge health care providers, patients and caregivers to be aware of the information the FDA is providing today so they can make informed treatment decisions,” Gottlieb added. “The FDA will continue to monitor the safety of these and other medical devices involved in the treatment of pain, and take action where needed to protect patients.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pain Management, Pharmaceuticals Tagged With: FDA

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Reader Interactions

Comments

  1. Steve says

    November 15, 2018 at 6:21 pm

    Huh? Use the wrong drug and the device is dangerous? Use the wrong drug and any delivery system is dangerous…! Actually the doc or nurse is dangerous for the error.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS